Background Genentech is the proprietor of European patent (UK) No. 1 641 822 entitled “Il-17A/F heterologous peptides and therapeutic uses thereof”. Genentech does not at present have a product covered by the patent but Lilly market an antibody under the...
Introduction This case relates to a European patent (EP2269603) in the name of Novartis relating to derivatives of rapamycin. Claim 1 of the patent covers: “40-O-(2-hydroxyethyl)-rapamycin in combination with exemestane for use in the treatment of hormone...
Can you patent a genetically modified organism? While Article 53(b) EPC is clear that essentially biological methods of producing an organism, i.e. crossing and selection, are not patentable there has been ongoing debate as to whether the organisms resulting from...
Almost two years after the signing of the agreement Helsinn filed a US provisional patent application, which ultimately lead to four patents. One of these patents, the ‘219 patent, being a continuation of the original application, specifically referred to a...
The time-consuming and costly regulatory review of new pharmaceuticals led to the Supplementary Protection Certificate (SPC) system being introduced in 1992. The SPC system is designed to compensate for the shortening in effective patent term that arises from the...
Does consuming two different types of goods at the same time increase their similarity? Asolo filed an application for registration of a European Union trade mark in 1997 for the word mark ‘FLÜGEL’ (‘wings’ in English) in classes 32 and 33....
Recent Comments